Multi-Cancer Early Detection
Early Detection of Women’s Cancers: A Prominent Role for Primary Care and OB/GYNs
Speakers: Lisa Larkin, MD, FACP, NCMP, IF, Founder and CEOMylynda Massart, MD, PhD, Assistant Professor, Department of Family Medicine
Duration: 60 minutes
Presented on: February 1, 2023
Lisa Larkin, MD, FACP, NCMP, IF
Lisa Larkin, MD, FACP, NCMP, IF
Founder and CEOLisa Larkin, MD, FACP, NCMP, IF, is a women’s health internist, menopause, sexual medicine, and medical breast expert and a physician and consumer educator who has been practicing in both academics and private practice for over 30 years. Dr. Larkin is passionate about raising the standard of care for women and advancing evidence-based women’s healthcare. She is Founder and CEO of Ms.Medicine, a national health care organization dedicated to advancing women’s health on a broader scale through innovation in care delivery models and consumer and clinician education. In addition, Dr. Larkin is Founder and President of Concierge Medicine of Cincinnati, a multispecialty practice, offering comprehensive primary care and women’s specialty health care through a direct care membership model.
Mylynda Massart, MD, PhD
Mylynda Massart, MD, PhD
Assistant Professor, Department of Family MedicineMylynda Massart, MD, PhD, is a board-certified Family Medicine physician at UPMC and assistant professor at the University of Pittsburgh. Currently, she serves as the Founder and Medical Director of the UPMC Primary Care Precision Medicine clinic and as the Associate Director of Clinical Services for the Institute for Precision Medicine. In addition, Dr. Massart is co-director for the HUB Core over Research Inclusivity and Community Partners Core at the Clinical and Translational Science Institute (CSTI). Her research interests are in developing education in genetics and precision medicine for primary care providers and trainees and to be a research catalyst facilitating the inclusion of underrepresented populations in biomedical research.
Early Detection of Women’s Cancers
A Prominent Role for Primary Care and OB/GYNs
ACKNOWLEDGEMENTThis activity is supported by an independent educational grant from GRAIL Inc.
DATE OF RELEASE/EXPIRATIONThis activity was released on February 1, 2023 and is valid until February 1, 2024. Requests for credit must be made no later than February 1, 2024.
TARGET AUDIENCEThe educational design of this activity addresses the needs of primary care physicians (PCPs), OB/GYNs, and NPs/PAs working in primary care or women’s care centers involved in the treatment of patients at higher risk for women’s cancers.
STATEMENT OF NEED/PROGRAM OVERVIEWMulti‐cancer early detection panels (MCEDs) have the potential to improve cancer outcomes by enhancing timely screening and detection of multiple cancers at once, including high‐incidence cancers without current guideline‐based screening. However, logistical challenges and practical questions need to be resolved to help clinicians integrate the MCED test into clinical practice.
OB/GYNs and other primary care physicians (PCPs) for women develop long‐lasting physician‐patient relationships and are aware of their patients’ values, histories, and preferences. Therefore, OB/GYN’s and PCPs are in a position to identify those at higher risk for women’s cancers and would qualify for early cancer screening.
Join an expert panel of PCPs and OB/GYNs as they discuss practical aspects of pan‐tumor screening, such as its value alongside current screening guidelines, selecting eligible patients, interpreting results, and ensuring referrals to specialists. Panelists will discuss the new paradigm in cancer diagnosis and review studies that provide real-world outcomes relevant to MCEDs in the clinical setting.
EDUCATIONAL OBJECTIVESAfter completing this activity, the participant should be better able to:
- Discuss the value proposition of MCEDs to improve long‐term outcomes for patients with cancers
- Analyze recent clinical data on MCEDs and their utility in early cancer detection
- Assess current data defining patients who are eligible for MCED testing by considering high‐risk characteristics and relevant clinical evidence
- Apply relevant approaches to facilitate the integration of MCEDs into clinical practice and transition patients from primary to oncology care
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATIONPACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ESTIMATED TIME TO COMPLETEThis activity should take approximately 60 minutes to complete.
INSTRUCTIONS TO RECEIVE CREDITIn order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTSParticipants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FEE INFORMATION & REFUND/CANCELLATION POLICYThere is no fee for this educational activity.
FACULTY AND DISCLOSURE OF CONFLICTS OF INTERESTPACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Faculty Conflicts of Interest Lisa Larkin, MD, FACP, NCMP, IF
Founder and CEO
Advisor, Consultant, Speaker: Astellas; Avion; Myovant; Pharmavite; Scynexis; Solv Wellness; and Therapeutics MD Mylynda B. Massart, MD, PHD
Department of Family Medicine
University of Pittsburgh
Advisor, Consultant, Speaker: GRAIL Inc.
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
DISCLOSURE OF UNLABELED USEThis educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER:Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accreditation Support:For additional information about the accreditation of this activity, please visit https://partnersed.com.
Technical Support:For any technical issues or issues with your CME Certificate, please contact OMedLive or ClinicalsSeriesLive at 877-394-1306 or at Support@OMedLive.com or Support@ClinicalSeriesLive.com.